fd2eb131fa03ffe01b0a963ac2f62b9c

Sensititre OptiRead™ V3030

TREK DIAGNOSTIC SYSTEMS LTD.·I·Ecuador ARCSA·Registered December 12, 2022
Device classification
Risk class
I
Product type
In Vitro Diagnostic
Brand name
SENSITITRE®
Commercial name
15-306 Analyzers, Laboratory, Microbiology, Susceptibility, Automated
Registration information
Analysis ID
fd2eb131fa03ffe01b0a963ac2f62b9c
Registration date
December 12, 2022
Expiration date
December 12, 2027
Manufacturer
City
EAST GRINSTEAD
Country
UNITED KINGDOM OF GREAT BRITAIN
Address
UNITS 17-19 BIRCHES INDUSTRIAL ESTATE
Product owner
Name
TREK DIAGNOSTIC SYSTEMS LTD.
Country
UNITED KINGDOM OF GREAT BRITAIN
Authorized representative
Address
URDESA CENTRAL AV. VICTOR EMILIO ESTRADA 917 BETWEEN HIGUERAS AND ILANES
Phone
2881414
Product use

THE SENSITITRE OPTIREAD™ IS AN ALTERNATIVE MANUAL READING METHOD DESIGNED FOR USE WITH THE SENSITITRE® MIC OR BP SUSCEPTIBILITY TESTING SYSTEM. IT IS A FLUORESCENCE-BASED DETECTION INSTRUMENT THAT IS USED TO READ SENSITIVE® SUSCEPTIBILITY PLATES THROUGH THE USE OF SOFTWARE AND A MONITOR.

About this record

Access comprehensive regulatory information for Sensititre OptiRead™ V3030 in the Ecuador medical device market through Pure Global AI's free database. This I medical device is registered under ARCSA ID fd2eb131fa03ffe01b0a963ac2f62b9c and manufactured by TREK DIAGNOSTIC SYSTEMS LTD.. The device was registered on December 12, 2022.

This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.